Tag:
BioDelivery Sciences International
Latest Headlines
Latest Headlines
Endo grabs BDSI's drug film chronic pain treatment through global license
BioDelivery Sciences International ( $BDSI )'s dissolvable drug delivery film to treat chronic pain from inside the cheek is still under development and endured a recent clinical setback. But it's
FDA issues new guidelines for transmucosal delivery of pain drug
As of Dec. 29, the FDA has placed every product featuring the transmucosal delivery of fentanyl under a single Risk Evaluation and Mitigation Strategy, also known as REMS. Fentanyl is used to treat
